INFUSYSTEM HOLDINGS, INC Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net (Deprecated 2018-01-31)
INFUSYSTEM HOLDINGS, INC (INFU) reported Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net (Deprecated 2018-01-31) of $1.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-28.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet · last filed 2013-03-28
- INFUSYSTEM HOLDINGS, INC derivative instruments, gain (loss) recognized in other comprehensive income (loss), effective portion, net (deprecated 2018-01-31) for the quarter ending 2012-12-31 was $0.00.
- INFUSYSTEM HOLDINGS, INC derivative instruments, gain (loss) recognized in other comprehensive income (loss), effective portion, net (deprecated 2018-01-31) for the quarter ending 2012-09-30 was $0.00.
- INFUSYSTEM HOLDINGS, INC derivative instruments, gain (loss) recognized in other comprehensive income (loss), effective portion, net (deprecated 2018-01-31) for fiscal 2012 was $1.00K.
- INFUSYSTEM HOLDINGS, INC derivative instruments, gain (loss) recognized in other comprehensive income (loss), effective portion, net (deprecated 2018-01-31) for fiscal 2011 was -$158.00K.
| Period end | Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net (Deprecated 2018-01-31) 3 month | Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net (Deprecated 2018-01-31) 6 month | Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net (Deprecated 2018-01-31) 9 month | Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $0.00 derived: sum of 2 quarters · filed 2013-03-28 | $1.00K 10-K · filed 2013-03-28 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $1.00K 10-Q · filed 2012-11-14 | ||
| 2012-06-30 | $1.00K 10-Q · filed 2012-08-08 | |||
| 2011-12-31 | -$158.00K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |